Acadian Asset Management LLC Royalty Pharma PLC Transaction History

Acadian Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$26.26 - $29.9 $249,890 - $284,528	9,516 New	9,516 $250,000
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $954,751 - $1.06 Million	36,427 Added 34.25%	142,790 $4.01 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $1.56 Million - $1.87 Million	59,596 Added 127.43%	106,363 $2.88 Million
Q2 2023 Aug 07, 2023	BUY	$29.6 - $36.56 $1.29 Million - $1.59 Million	43,625 Added 1388.45%	46,767 $1.44 Million
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $102,963 - $123,794	3,142 New	3,142 $113,000
Q2 2022 Aug 09, 2022	BUY	$37.53 - $44.22 $922,149 - $1.09 Million	24,571 New	24,571 $1.03 Million
Q1 2021 May 11, 2021	SELL	$42.34 - $52.82 $33,109 - $41,305	-782 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$36.12 - $50.05 $96,765 - $134,083	-2,679 Reduced 77.41%	782 $39,000
Q3 2020 Nov 09, 2020	BUY	$38.56 - $48.36 $133,456 - $167,373	3,461 New	3,461 $146,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.